Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Filociclovir Is a PotentIn VitroandIn VivoInhibitor of Human Adenoviruses

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01299-20Source: DataRank Database

Filociclovir Is a PotentIn VitroandIn VivoInhibitor of Human Adenoviruses is a research paper published in Antimicrobial Agents and Chemotherapy (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.31)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Islam T. M. Hussein,Ann E. Tollefson ORCID,Baoling Ying,Jacqueline F. Spencer ORCID,Jessica Eagar

Live enrichment

PubMed:32816736 PMC:PMC7577159 OpenAlex:https://openalex.org/W3057593170

HHS | National Institutes of Health

Grant: HHSN272201700041I

HHS | National Institutes of Health

Grant: HHSN27200006/A14

HHS | National Institutes of Health

Grant: HHSN272201100016I

NIAID NIH HHS

Grant: HHSN272201100016C

FWCI

1.31

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

greenLicense: https://journals.asm.org/non-commercial-tdm-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7577159

publisherhttps://journals.asm.org/doi/pdf/10.1128/AAC.01299-20

journalhttps://doi.org/10.1128/aac.01299-20

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32816736

Fields of Study

Cytomegalovirus and herpesvirus researchVirus-based gene therapy researchRespiratory viral infections researchAdenovirus Infections, HumanAdenoviruses, HumanAnimalsAntiviral AgentsCricetinaeCytomegalovirus InfectionsHumansVirus Replication

MeSH Terms

Adenovirus Infections, HumanAdenoviruses, HumanAnimalsAntiviral AgentsCytomegalovirus InfectionsCricetinaeHumansVirus Replication

Keywords

Human cytomegalovirusIn vivoGanciclovirVirologyKeratoconjunctivitisPneumoniaNucleoside analogueAntiviral drugDrugPopulationCytomegalovirusIn vitroMedicineBetaherpesvirinaeImmunologyBiologyVirusHerpesviridaeViral diseaseNucleosidePharmacologyInternal medicineAdenovirusesAntiviralFilociclovir

Sustainable Development Goals

SDG 0: Good health and well-being